NEUROPEPTIDES AND NASAL SECRETION

被引:62
|
作者
BARANIUK, JN
KALINER, M
机构
[1] NIAID, CLIN INVEST LAB, ALLERG DIS SECT, BETHESDA, MD 20892 USA
[2] NATL HEART & LUNG INST, DEPT THORAC MED, LONDON SW3 6LY, ENGLAND
来源
AMERICAN JOURNAL OF PHYSIOLOGY | 1991年 / 261卷 / 04期
关键词
SUBSTANCE-P; NEUROKININ-A; TACHYKININS; CALCITONIN GENE-RELATED PEPTIDE; VASOACTIVE INTESTINAL PEPTIDE; NEUROPEPTIDE-Y; MUCUS SECRETION; VASCULAR PERMEABILITY;
D O I
10.1152/ajplung.1991.261.4.L223
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
The nasal mucosa is innervated by the sensory, parasympathetic, and sympathetic nervous systems. Nociceptive sensory nerves are stimulated by mucosal injury, inhalation of irritants, or mast cell degranulation and release of the calcitonin gene-related peptide, the tachykinins substance P and neurokinin A, and other peptides by the axon response mechanism. Sensory nerve stimulation initiates systemic reflexes, such as the sneeze, and central parasympathetic reflexes which release acetylcholine, vasoactive intestinal peptide, and other peptides and lead to glandular secretion. In concert, these proinflammatory neural responses lead to vasodilation, vascular permeability, and glandular secretion. Sympathetic nerves release neuropeptide Y and norepinephrine, potent vasoconstrictors which act to decompress the nasal mucosa and produce nasal patency. The balance between the effects of parasympathetic and sympathetic neurotransmitters may regulate nasal homoeostasis, whereas the nociceptive sensory system may be held in reserve as a defense mechanism. Dysfunction of these systems may lead to pathological nasal syndromes. In the future, specific neuropeptide agonists and antagonists may be useful for the treatment of human rhinitic diseases.
引用
收藏
页码:L223 / L235
页数:13
相关论文
共 50 条
  • [1] NEUROPEPTIDES AND NASAL SECRETION
    BARANIUK, JN
    KALINER, MA
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1990, 86 (04) : 620 - 627
  • [2] NEUROPEPTIDES AND SECRETION
    EKSTROM, J
    JOURNAL OF DENTAL RESEARCH, 1987, 66 (02) : 524 - 530
  • [3] NEUROPEPTIDES IN NASAL-MUCOSA
    WOOHEAD, CJ
    CLINICAL OTOLARYNGOLOGY, 1994, 19 (04) : 277 - 286
  • [4] NASAL NEUROPEPTIDES AND ALLERGIC RHINITIS
    FAJAC, I
    FROSSARD, N
    REVUE DES MALADIES RESPIRATOIRES, 1994, 11 (04) : 357 - 367
  • [5] THE EFFECTS OF NEUROPEPTIDES ON MUCOUS GLYCOPROTEIN-SECRETION FROM HUMAN NASAL-MUCOSA INVITRO
    MULLOL, J
    RIEVES, RD
    BARANIUK, JN
    LUNDGREN, JD
    MERIDA, M
    HAUSFELD, JH
    SHELHAMER, JH
    KALINER, MA
    NEUROPEPTIDES, 1992, 21 (04) : 231 - 238
  • [6] PRESENCE OF NEUROPEPTIDES IN HUMAN NASAL POLYPS
    FANG, SY
    SHEN, CL
    OHYAMA, M
    ACTA OTO-LARYNGOLOGICA, 1994, 114 (03) : 324 - 328
  • [7] NEUROPEPTIDES IN THE HUMAN NASAL-MUCOSA
    HAUSERKRONBERGER, C
    HACKER, GW
    MUSS, W
    ALBEGGER, K
    ALLERGOLOGIE, 1994, 17 (05) : 183 - 196
  • [8] THE SECRETORY VESICLE IN PROCESSING AND SECRETION OF NEUROPEPTIDES
    RUSSELL, JT
    CURRENT TOPICS IN MEMBRANES AND TRANSPORT, 1987, 31 : 277 - 312
  • [9] NEUROPEPTIDES AND AIRWAY SUBMUCOSAL GLAND SECRETION
    SHIMURA, S
    SASAKI, T
    IKEDA, K
    ISHIHARA, H
    SATO, M
    SASAKI, H
    TAKISHIMA, T
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 143 (03): : S25 - S27
  • [10] NEUROPEPTIDES AND ISLET HORMONE-SECRETION
    AHREN, B
    TABORSKY, GJ
    ACTA PHYSIOLOGICA SCANDINAVICA, 1985, 124 : 312 - 312